Palo Alto Health Sciences Obtains FDA-Clearance for Freespira in Treating Post-Traumatic Stress Disorder
PRNewswire | December 18, 2018 KIRKLAND, Wash., Dec. 18, 2018 /PRNewswire/ — Palo Alto Health Sciences, Inc. (PAHS) announced today that its flagship…
Read More
